Daniel Harris

518 total citations
20 papers, 198 citations indexed

About

Daniel Harris is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Daniel Harris has authored 20 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Daniel Harris's work include Atrial Fibrillation Management and Outcomes (6 papers), Lipoproteins and Cardiovascular Health (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Daniel Harris is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Lipoproteins and Cardiovascular Health (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Daniel Harris collaborates with scholars based in United Kingdom, Denmark and Australia. Daniel Harris's co-authors include Julian Halcox, Howard E. Savage, Ashley Akbari, Jatin P. Shah, A. Katz, Andrew G. Huvos, Stimson P. Schantz, Guo‐Pei Yu, R. R. Alfano and Fatemeh Torabi and has published in prestigious journals such as PLoS ONE, European Heart Journal and Epilepsia.

In The Last Decade

Daniel Harris

20 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Harris United Kingdom 6 48 47 39 30 28 20 198
Anna Maria Meyer Germany 10 18 0.4× 15 0.3× 14 0.4× 17 0.6× 8 0.3× 26 258
Michiel A. de Graaf Netherlands 6 39 0.8× 51 1.1× 30 0.8× 36 1.2× 2 0.1× 6 140
Leenhapong Navaravong United States 11 293 6.1× 31 0.7× 22 0.6× 42 1.4× 9 0.3× 58 370
Liyan Huang China 9 90 1.9× 16 0.3× 11 0.3× 31 1.0× 18 0.6× 36 232
Sharon Kean United Kingdom 6 23 0.5× 17 0.4× 9 0.2× 44 1.5× 8 0.3× 10 212
Karina V Bunting United Kingdom 10 360 7.5× 32 0.7× 70 1.8× 43 1.4× 3 0.1× 27 462
Luigi Spadafora Italy 9 157 3.3× 30 0.6× 39 1.0× 48 1.6× 1 0.0× 52 276
Zhiwei Yan China 7 55 1.1× 9 0.2× 45 1.2× 24 0.8× 34 1.2× 20 243
А. Yu. Suvorov Russia 10 144 3.0× 59 1.3× 60 1.5× 41 1.4× 75 325
Marco Mercader United States 8 406 8.5× 14 0.3× 45 1.2× 68 2.3× 19 499

Countries citing papers authored by Daniel Harris

Since Specialization
Citations

This map shows the geographic impact of Daniel Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Harris more than expected).

Fields of papers citing papers by Daniel Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Harris. The network helps show where Daniel Harris may publish in the future.

Co-authorship network of co-authors of Daniel Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Harris. A scholar is included among the top collaborators of Daniel Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Harris. Daniel Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harris, Daniel, et al.. (2024). Trends in atherosclerotic cardiovascular disease and lipid management: a population-level observational cohort study in Wales. European Journal of Preventive Cardiology. 31(15). 1778–1789. 3 indexed citations
3.
4.
5.
Torabi, Fatemeh, Ashley Akbari, Jane Lyons, et al.. (2022). Impact of COVID-19 pandemic on community medication dispensing: a national cohort analysis in Wales, UK. International Journal for Population Data Science. 5(4). 3 indexed citations
6.
Harrison, Stephanie L., Peter E. Penson, Ashley Akbari, et al.. (2022). Anticoagulation in older people with atrial fibrillation moving to care homes: a data linkage study. British Journal of General Practice. 73(726). e43–e51. 4 indexed citations
7.
Ellins, Elizabeth A., Daniel Harris, Arron Lacey, et al.. (2022). Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sex. PLoS ONE. 17(2). e0264529–e0264529. 4 indexed citations
8.
Torabi, Fatemeh, Daniel Harris, Owen Bodger, et al.. (2022). Identifying unmet antithrombotic therapeutic need, and implications for stroke and systemic embolism in atrial fibrillation patients: a population-scale longitudinal study. European Heart Journal Open. 2(6). oeac066–oeac066. 1 indexed citations
9.
Harrison, Stephanie L., Gregory Y.H. Lip, Ashley Akbari, et al.. (2022). Stroke in Older Adults Living in Care Homes: Results From a National Data Linkage Study in Wales. Journal of the American Medical Directors Association. 23(9). 1548–1554.e11. 3 indexed citations
10.
Harrison, Stephanie L., Peter E. Penson, Ashley Akbari, et al.. (2022). Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018. Age and Ageing. 51(12). 11 indexed citations
11.
Harrison, Stephanie L., Peter E. Penson, Ashley Akbari, et al.. (2022). Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003–2018. European Heart Journal. 43(Supplement_2). 1 indexed citations
12.
Torabi, Fatemeh, Arron Lacey, Beata Fonferko‐Shadrach, et al.. (2021). Epilepsy, antiepileptic drugs, and the risk of major cardiovascular events. Epilepsia. 62(7). 1604–1616. 34 indexed citations
13.
Kurdi, Hibba, et al.. (2021). Eligibility for dapagliflozin in unselected patients hospitalised with decompensated heart failure. British Journal of Cardiology. 28(2). 18–18. 1 indexed citations
14.
Thayer, Daniel, et al.. (2020). Measuring follow-up time in routinely-collected health datasets: Challenges and solutions. PLoS ONE. 15(2). e0228545–e0228545. 15 indexed citations
15.
Harris, Daniel, Arron Lacey, Ashley Akbari, et al.. (2020). Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort study. European Journal of Preventive Cardiology. 28(8). 854–861. 18 indexed citations
16.
Harris, Daniel, Daniel Thayer, Ting Wang, et al.. (2019). An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS). European Heart Journal - Cardiovascular Pharmacotherapy. 7(1). 40–49. 2 indexed citations
17.
Harris, Daniel, Arron Lacey, Ashley Akbari, et al.. (2019). Early Discontinuation of P2Y 12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort. Journal of the American Heart Association. 8(21). e012812–e012812. 3 indexed citations
18.
Wheeler, Amanda, et al.. (2013). Review of undergraduate research education for pharmacy students in New Zealand, Australia and the United Kingdom. Currents in Pharmacy Teaching and Learning. 5(3). 180–190. 2 indexed citations
19.
Gordon, David, Curtiss B. Cook, W. Douglas Scheer, et al.. (1999). Diabetes and obesity in the Louisiana Coushatta Indians.. PubMed. 9(1). 48–58. 9 indexed citations
20.
Schantz, Stimson P., Howard E. Savage, Guo‐Pei Yu, et al.. (1998). In vivo native cellular fluorescence and histological characteristics of head and neck cancer.. PubMed. 4(5). 1177–82. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Maria Meyer Breakdown of academic impact, for papers by Michiel A. de Graaf Breakdown of academic impact, for papers by Leenhapong Navaravong Breakdown of academic impact, for papers by Liyan Huang Breakdown of academic impact, for papers by Sharon Kean Breakdown of academic impact, for papers by Karina V Bunting Breakdown of academic impact, for papers by Luigi Spadafora Breakdown of academic impact, for papers by Zhiwei Yan Breakdown of academic impact, for papers by А. Yu. Suvorov Breakdown of academic impact, for papers by Marco Mercader
Rankless by CCL
2026